Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphomaD C Betticher, E Zucca, A von Rohr, et al.British Journal of Haematology|December 31, 1997
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, S F Hsu Schmitz, D Ratschiller, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphomaD C Betticher, A von Rohr, D Ratschiller, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II studyA von Rohr, S-F H Schmitz, A Tichelli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2006
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL)D C Betticher, G Martinelli, J A Radford, et al.Pageof 2